Pre-hospital thrombolysis in ST-segment elevation myocardial infarction: a regional Australian experience
The known Pre-hospital thrombolysis in patients with ST-segment elevation myocardial infarction (STEMI) has been found to be an effective strategy in randomised controlled trials.
The new Pre-hospital thrombolysis is safe and effective in the real world setting, especially in a region where transport distances to the cardiac catheterisation laboratory are great.
The implications Pre-hospital thrombolysis can be implemented in regions where timely primary percutaneous coronary intervention for STEMI patients is not available.
Primary percutaneous coronary intervention (PCI), if performed in a timely manner, is the preferred reperfusion strategy for patients with an ST-segment elevation myocardial infarction (STEMI).1 However, physicians in regions geographically isolated from a primary PCI centre are unable to perform PCI rapidly, and the optimal reperfusion strategy is therefore undefined. Recent guidelines have highlighted the importance of systems-based approaches to STEMI management, taking into account regional characteristics.2 In Australia, many patients are a long way from a primary PCI centre, and these patients usually receive thrombolysis in hospitals that are not PCI-capable. However, if reperfusion with thrombolysis fails or a contraindication…